Aspirin in Primary Prevention- When to Consider? Dr A B Chandorkar9 May 2025 11:16 AM ISTReframing Aspirin's Role in Primary Prevention: Evolving evidence has refined our understanding of aspirin's role in primary prevention. While earlier...
Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates Dr. Salil Vaidya28 April 2025 10:25 AM ISTCVD Risk in Women After 40: Cardiovascular disease (CVD) is the leading cause of death in individuals with type 2 diabetes (T2D) and hypertension. (1)...
Indian CV Risk Factors and Emerging Evidence for Aspirin in Primary Prevention- What's New? Dr. Jay Shah5 April 2025 11:32 AM ISTCardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable...
Lipoprotein(a), ASCVD risk, and Aspirin- What is the Latest Evidence Saying? Dr. Roopali Khanna7 Feb 2025 12:21 PM ISTLipoprotein (a) [Lp(a)] is considered pro-atherosclerotic, pro-inflammatory, pro-thrombotic, and anti-fibrinolytic. Lipoprotein(a) levels >50 mg/dL...
Metoprolol in Coronary Artery Disease: Top 5 Evidence Insights Dr. S. N. Routray6 Feb 2025 11:41 AM ISTCoronary Artery Disease-A Concerning Epidemiology in India:India has the highest burden of acute coronary syndrome and ST-elevation myocardial...
Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
Primary Prevention with Aspirin: Lowering ASCVD Mortality in Adults with Elevated Lipoprotein(a) Dr Prakash Kumar19 Nov 2024 9:15 AM ISTQuick Takeaways:Elevated Lp(a) (>=50 mg/dL) significantly raises ASCVD risk, affecting around 25% of Indians.One-time Lp(a) screening in adulthood...
Metoprolol: Applicability in Young Hypertensives in India Dr. Debopriyo Mondal11 Nov 2024 12:31 PM ISTHypertension affects 1 in 8 adults aged between 20 and 40 years. The prevalence of hypertension among adults in India is about 25 to 42% and three...
Theory to Practice: Implementing Aspirin and Statin Therapy in Primary Care Settings Dr Nishant Tripathi5 Nov 2024 9:00 AM ISTPremature ASCVD in IndiaThe prevalence of atherosclerotic cardiovascular disease (ASCVD) has been increasing in India, surpassing infectious diseases...
CVD Care Continuum in 2024: Metoprolol Revisited Dr Johann Christopher25 Oct 2024 11:02 AM ISTCoronary artery disease (CAD) is a significant group within cardiovascular diseases (CVD) that results from decreased myocardial perfusion, leading to...
Revolutionizing COPD Care: The Role Of Pneumococcal Vaccines in Enhancing Patient Outcomes Dr Rajesh V11 Oct 2024 12:00 PM ISTExacerbations are recognized to be crucial acute events that are associated with increased hospitalization rates and worsening clinical outcomes. Both...
Impact of Regular Aspirin Use on ASCVD Mortality in Adults with Elevated Lipoprotein(a) Levels Prof. Soumitra Kumar1 Oct 2024 12:52 PM ISTWith a rising incidence of cardiovascular disease (CVD) among younger individuals aged below 55 years(1),particularly in India, where it occurs about...
